Table 2

Experiment A: Carrageenan edema and oral administration

Drug
Paw volume increase over time (ml ± SD) and effect (% of negative control)



1 hr

3 hr

5 hr

7 hr


Saline
0.57 ± 0.14

0.98 ± 0.13

0.93 ± 0.14

0.79 ± 0.14










Arnica D4
0.46 ± 0.12
-18
0.98 ± 0.14
0
0.85 ± 0.12
-8
0.72 ± 0.11
-9
Apis D4
0.42 ± 0.12
-26
0.90 ± 0.15
-8
0.77 ± 0.14
-17
0.65 ± 0.15
-18
Atropa D4
0.44 ± 0.09
-22
0.94 ± 0.16
-4
0.80 ± 0.18
-14
0.73 ± 0.17
-7
Hamamelis D4
0.49 ± 0.11
-14
0.88 ± 0.14
-10
0.78 ± 0.17
-16
0.68 ± 0.14
-14
Lachesis D6
0.41 ± 0.10
-28
0.87 ± 0.18
-11
0.81 ± 0.17
-12
0.62 ± 0.18
-21
Phosphorus D6
0.41 ± 0.13
-28
0.86 ± 0.14
-12
0.78 ± 0.13
-16
0.65 ± 0.11
-18









Indomethacin i.m.
0.38 ± 0.14
-34
0.63 ± 0.18
-36
0.59 ± 0.18
-36
0.49 ± 0.18
-38

ANOVA results. Treatment: F(7,136) = 8.38, p < 0.0001; Time: F(3,408) = 674.23, p < 0.0001; Treatment × time: F(21,408) = 3.65, p < 0.0001.

Bold characters denote significant comparisons (by Student t test) vs. Saline group corresponding for time since edema induction.

Conforti et al. BMC Complementary and Alternative Medicine 2007 7:1   doi:10.1186/1472-6882-7-1